Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Light-controlled microenvironment for Advanced organoids with Neural tube and somite Tissues Engineered with Responsive Nanoparticles

Project description

Opening a window into human neural development

While neural tube defects (NTDs) are common birth defects, affecting over 300 000 births annually, little is known about their origins in human embryos. Supported by the Marie Skłodowska-Curie Actions, the LANTERN project aims to study this by creating an in vitro model of the human neural tube. It will use advanced organoids and cutting-edge bioengineering, including light-responsive gold nanorods and dynamically reshaped hydrogels. Researchers will use this to replicate the spatial and temporal signals that drive embryonic patterning. Ultimately, this allows for the investigation of molecular and mechanical causes of defects without relying on animal studies. The goal is to develop a tool for drug screening and reinforce Europe’s leadership in biomedical research.

Objective

Neural tube (NT) defects, such as spina bifida and encephalocele, affect over 300000 births worldwide each year and originate from alterations in the earliest stages of embryogenesis. Understanding their causes remains challenging because human NT development is inaccessible to direct investigation. To overcome this limitation, LANTERN aims to create a dynamic and shape-controlled reproducible in vitro model of human NT development using hiPSC-derived Neural tube and Somites Advanced Organoids (NSAO). The main objective is to reproduce, with unprecedented precision, the spatial and temporal signals that drive NT patterning, thereby providing a reliable platform to study NT defects.
The project integrates complementary innovations: (i) a biomimetic hydrogel niche, engineered from extracellular matrix-like biopolymers and dynamically reshaped through multiphoton microscopy; (ii) nanoparticle-mediated morphogen delivery, exploiting photosensitive gold nanorods to establish adaptive gradients of morphogens; (iii) advanced organoid culture, where NSAO grow under controlled mechanical constraints and are exposed to tunable morphogen sources. Together, these technologies will yield reproducible tissue architecture and accurate dorsal-ventral axis regionalization, validated through advanced imaging and RNA sequencing.
By integrating bioengineering, nanotechnology, and stem cell biology, LANTERN goes beyond the state of the art in organoid systems, scaffolds, and morphogen delivery strategies. The outcomes will provide a robust model to identify the molecular and mechanical causes of NT defects, reduce reliance on animal studies, and establish a platform with translational potential for drug screening. Aligned with the MSCA work programme, the fellowship will foster interdisciplinary training, enhance the researcher’s independence and employability, and contribute to Europe’s leadership in innovative and ethically responsible biomedical research.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

UNIVERSITA DEGLI STUDI DI PADOVA
Net EU contribution
€ 193 643,28
Address
VIA 8 FEBBRAIO 2
35122 Padova
Italy
Region
Nord-Est Veneto Padova
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data